Lucı́a Villalón

823 total citations
25 papers, 400 citations indexed

About

Lucı́a Villalón is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Lucı́a Villalón has authored 25 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Genetics and 7 papers in Oncology. Recurrent topics in Lucı́a Villalón's work include Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lysosomal Storage Disorders Research (4 papers). Lucı́a Villalón is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Lysosomal Storage Disorders Research (4 papers). Lucı́a Villalón collaborates with scholars based in Spain, France and Argentina. Lucı́a Villalón's co-authors include J Odriozola, César Henríquez-Camacho, Juan Emilio Losa, J. L. Steegmann, Elena Fernández‐Ruiz, Miguel Á. Piris, Joaquín Martínez‐López, Lorraine Tracey, J García Laraña and Raquel Villuendas and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Lucı́a Villalón

24 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucı́a Villalón Spain 11 224 142 107 63 61 25 400
Kenneth Washenik United States 5 132 0.6× 59 0.4× 52 0.5× 69 1.1× 64 1.0× 7 409
M Masuda Japan 10 173 0.8× 72 0.5× 118 1.1× 70 1.1× 42 0.7× 22 382
Elizabeth Klein United States 9 276 1.2× 152 1.1× 59 0.6× 81 1.3× 72 1.2× 32 510
Mohcine Bennani Mechita Morocco 13 87 0.4× 96 0.7× 60 0.6× 109 1.7× 25 0.4× 36 381
Soken-Nakazawa J. Song Japan 5 212 0.9× 133 0.9× 71 0.7× 40 0.6× 82 1.3× 8 364
Corinne Duguet France 6 223 1.0× 56 0.4× 131 1.2× 139 2.2× 154 2.5× 7 530
Delphine Oguey Switzerland 10 191 0.9× 67 0.5× 56 0.5× 68 1.1× 47 0.8× 13 383
A. Covelli Italy 11 134 0.6× 95 0.7× 174 1.6× 158 2.5× 17 0.3× 23 447
Éric Grignano France 9 146 0.7× 88 0.6× 98 0.9× 191 3.0× 45 0.7× 23 452
AK Burnett United Kingdom 9 346 1.5× 204 1.4× 37 0.3× 64 1.0× 41 0.7× 16 469

Countries citing papers authored by Lucı́a Villalón

Since Specialization
Citations

This map shows the geographic impact of Lucı́a Villalón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucı́a Villalón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucı́a Villalón more than expected).

Fields of papers citing papers by Lucı́a Villalón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucı́a Villalón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucı́a Villalón. The network helps show where Lucı́a Villalón may publish in the future.

Co-authorship network of co-authors of Lucı́a Villalón

This figure shows the co-authorship network connecting the top 25 collaborators of Lucı́a Villalón. A scholar is included among the top collaborators of Lucı́a Villalón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucı́a Villalón. Lucı́a Villalón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torrent, Anna, Mireia Morgades, Maria Paz Queipo De Llano, et al.. (2023). Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain. European Journal Of Haematology. 111(3). 485–490. 2 indexed citations
2.
Martinez‐Barranco, Pilar, María Velasco, Carlos Guijarro, et al.. (2021). Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma. Acta Haematologica. 145(4). 384–393. 13 indexed citations
3.
Andrade‐Campos, Marcio, J L Capablo, Mercedes Roca‐Espiau, et al.. (2018). Twenty-Five Years Diagnosing Gaucher’s Disease in Spain, What We Have Learned?. Blood. 132(Supplement 1). 1110–1110.
4.
Osorio, Santiago, Vicente Escudero‐Vilaplana, Ignacio Gómez‐Centurión, et al.. (2018). Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?. Annals of Hematology. 97(11). 2089–2098. 18 indexed citations
5.
Villalón, Lucı́a, et al.. (2014). Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update. Advances in Hematology. 2014. 1–9. 47 indexed citations
6.
Ferraro, Simona, et al.. (2014). Air particulate matter exacerbates lung response on Sjögren's Syndrome animals. Experimental and Toxicologic Pathology. 67(2). 125–131. 10 indexed citations
7.
Giraldo, Pilar, Pilar Alfonso, Pilar Irún, et al.. (2013). Substrate Reduction Therapy With Miglustat In Type 1 Gaucher Disease In Spain. Nine Years Outcomes Update On ZAGAL Study. Blood. 122(21). 4713–4713. 4 indexed citations
8.
Irún, Pilar, C. Domínguez, Victor Rodríguez‐Sureda, et al.. (2012). Identification of seven novel SMPD1 mutations causing Niemann–Pick disease types A and B. Clinical Genetics. 84(4). 356–361. 21 indexed citations
9.
Villalón, Lucı́a, et al.. (2011). Linfoma B esplénico de la zona marginal con afectación cutánea epidermotropa. Actas Dermo-Sifiliográficas. 103(5). 427–431. 8 indexed citations
10.
Vallejo, Carlos, Eduardo Ríos, Javier de la Serna, et al.. (2011). Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab. Expert Review of Hematology. 4(1). 9–16. 15 indexed citations
11.
Giraldo, Pilar, Pilar Irún, Pilar Alfonso, et al.. (2010). Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage. Blood Cells Molecules and Diseases. 46(1). 115–118. 26 indexed citations
12.
Subirá, Dolores, Patricia Font, Lucı́a Villalón, et al.. (2008). Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?. Translational research. 151(5). 240–245. 18 indexed citations
13.
Subirá, Dolores, Patricia Font, Lucı́a Villalón, et al.. (2007). Immunophenotype in Chronic Myelomonocytic Leukemia: Is It Closer to Myelodysplastic Syndromes or to Myeloproliferative Disorders?.. Blood. 110(11). 4621–4621. 1 indexed citations
14.
Villuendas, Raquel, J. L. Steegmann, Marina Pollán, et al.. (2006). Identification of genes involved in imatinib resistance in CML: a gene-expression profiling approach. Leukemia. 20(6). 1047–1054. 84 indexed citations
15.
Cervantes, Francisco, Juan Carlos Hernández‐Boluda, J Odriozola, et al.. (2003). Imatinib mesylate (STI571) treatment in patients with chronic‐phase chronic myelogenous leukaemia previously submitted to autologous stem cell transplantation. British Journal of Haematology. 120(3). 500–504. 8 indexed citations
16.
Quijano, Yolanda, P. Cabanelas, C Redondo, et al.. (2002). Origin and immunophenotype of intestinal intraepithelial lymphocytes in experimental long-surviving small bowel allografts. Transplantation Proceedings. 34(1). 221–223. 1 indexed citations
17.
Villalón, Lucı́a, J Odriozola, J García Laraña, et al.. (2000). Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment.. PubMed. 1(6). 374–81. 34 indexed citations
18.
Villalón, Lucı́a, J Odriozola, J García Laraña, et al.. (2000). Autologous peripheral blood progenitor cell transplantation with <2×106 CD34+/kg: an analysis of variables concerning mobilisation and engraftment. The Hematology Journal. 1(6). 374–381. 25 indexed citations
19.
Villalón, Lucı́a, Jesús M. Cesar, J Odriozola, et al.. (2000). Is Veno-occlusive Disease a Specific Syndrome or the Exacerbation of Physiopathologic Hemostatic Changes in Hematopoietic Stem Cell Transplantation (HSCT)?. Thrombosis Research. 99(5). 439–446. 9 indexed citations
20.
Bizouarn, Philippe, et al.. (1990). Transplantation hépatique pour métastases d'une tumeur carcinoïde. Annales Françaises d Anesthésie et de Réanimation. 9(2). 180–182. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth Washenik Breakdown of academic impact, for papers by M Masuda Breakdown of academic impact, for papers by Elizabeth Klein Breakdown of academic impact, for papers by Mohcine Bennani Mechita Breakdown of academic impact, for papers by Soken-Nakazawa J. Song Breakdown of academic impact, for papers by Corinne Duguet Breakdown of academic impact, for papers by Delphine Oguey Breakdown of academic impact, for papers by A. Covelli Breakdown of academic impact, for papers by Éric Grignano Breakdown of academic impact, for papers by AK Burnett
Rankless by CCL
2026